TANTA UNIVERSITY
🇪🇬Egypt
- Country
- 🇪🇬Egypt
- Ownership
- Private
- Established
- 1972-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.tanta.edu.eg
Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis
Early Phase 1
Not yet recruiting
- Conditions
- Ulcerative Colitis
- Interventions
- Drug: conventional treatment
- First Posted Date
- 2022-11-09
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 60
- Registration Number
- NCT05610956
A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone
Phase 2
Completed
- Conditions
- Dermatologic Disease
- Interventions
- First Posted Date
- 2022-11-07
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 100
- Registration Number
- NCT05607901
- Locations
- 🇪🇬
Tanta Unuversity, Tanta, Egypt
Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis
Phase 3
Not yet recruiting
- Conditions
- Non Alcoholic Steatohepatitis
- Interventions
- First Posted Date
- 2022-11-04
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 56
- Registration Number
- NCT05605158
- Locations
- 🇪🇬
Tanta University, Tanta, Gharbiya, Egypt
Ultrasound Guided Erector Spinae Block vs Thoracolumbar Interfascial Plane Block
Not Applicable
Completed
- Conditions
- AnalgesiaLumbar Spine Disease
- Interventions
- Other: Erector spinae plane blockOther: Thoracolumbar interfascial plane block
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 180
- Registration Number
- NCT05596227
- Locations
- 🇪🇬
Mona Mohamed Mogahed, Tanta, Elgharbia, Egypt
Cilostazol and Methotrexate in Rheumatoid Arthritis
Phase 3
Recruiting
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2022-10-26
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 70
- Registration Number
- NCT05594680
- Locations
- 🇪🇬
Faculty of medicine, Mansoura, Egypt
Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients
Phase 2
- Conditions
- Peripheral NeuropathyCardiac ToxicitiesCognitive ImpairmentHepatic ToxicityBreast Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-10-26
- Last Posted Date
- 2022-10-26
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 56
- Registration Number
- NCT05595109
- Locations
- 🇪🇬
Tanta university, Tanta, Egypt
Itraconazole in Advanced Ovarian Cancer
Not Applicable
Not yet recruiting
- Conditions
- Ovarian Carcinoma
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-10-24
- Last Posted Date
- 2022-10-24
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 66
- Registration Number
- NCT05591560
- Locations
- 🇪🇬
Tanta University, Faculty of Pharmacy, Tanta, Egypt
Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer
Early Phase 1
- Conditions
- Colo-rectal CancerMucositisNeuropathy;Peripheral
- Interventions
- First Posted Date
- 2022-10-21
- Last Posted Date
- 2022-10-21
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 48
- Registration Number
- NCT05590117
- Locations
- 🇪🇬
Tanta University, Tanta, Gharbyia, Egypt
Comparative Study of Different Doses of Magnesium as a Protective Agent in Nephrotoxicity in Cancer Patients
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 75
- Registration Number
- NCT05586009
- Locations
- 🇪🇬
Mohamed Saad younis, Tanta, Gharbiya, Egypt
Uterine Artery Color Doppler Parameters After Bilateral Uterine Artery Ligation
Not Applicable
Completed
- Conditions
- Postpartum HemorrhageColor DopplerLigationUterine Artery
- Interventions
- Procedure: Control groupProcedure: BUAL group
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 70
- Registration Number
- NCT05584995
- Locations
- 🇪🇬
Ahmed M.E. Ossman, Tanta, El-Gharbia Governorate, Egypt
© Copyright 2025. All Rights Reserved by MedPath